2025-10-07T12:14:20-05:00 2024-12-31 871353108 EISNER ADVISORY GROUP LLC 733 THIRD AVENUE NEW YORK NY 100172703 990 2024-01-01 364825921 THE MARK FOUNDATION FOR CANCER RESEARCH (US) LTD MARK 6468665950 1350 AVENUE OF THE AMERICAS 2902 NEW YORK NY 10019 RYAN SCHOENFELD CEO 6468665950 2025-10-07 1 1 CANDICE METH P01306891 2129498700 2024 2025-03-06 01:10:19Z RYAN SCHOENFELD 1350 AVENUE OF THE AMERICAS 2902 NEW YORK NY 10019 48526753 0 X WWW.THEMARKFOUNDATION.ORG X 2015 NY ACCELERATE RESEARCH TO TRANSFORM PREVENTION, DIAGNOSIS AND TREATMENT OF CANCER. 6 5 9 11 0 0 39897754 44393676 0 0 1030138 409872 9740 -30647 40937632 44772901 29825753 30533067 0 0 3134023 2662168 0 0 1015545 2249721 2871515 35209497 36066750 5728135 8706151 104492388 105459714 20015419 13019944 84476969 92439770 PARTNER WITH SCIENTISTS TO ACCELERATE RESEARCH THAT WILL TRANSFORM THE PREVENTION, DIAGNOSIS, AND TREATMENT OF CANCER THROUGH GROUND BREAKING SCIENCE CARRIED OUT BY INDIVIDUAL INVESTIGATORS, MULTIDISCIPLINARY TEAMS, AND EARLY STAGE COMPANIES IN THE U.S AND ABROAD. 0 0 33898449 30533067 THE FOUNDATION'S GRANTS REWARD INNOVATIVE THINKING THAT ADVANCES THE UNDERSTANDING OF CANCER BIOLOGY AND IMPROVES ONCOLOGY TREATMENT PARADIGMS. THE FOUNDATION SUPPORTS INDIVIDUAL INVESTIGATORS, AS WELL AS MULTIDISCIPLINARY COLLABORATIVE TEAMS CONDUCTING RESEARCH ACROSS CANCER TYPES. THE GRANTEES BECOME PART OF THE FOUNDATION'S NETWORK OF THE BEST SCIENTIFIC MINDS IN CANCER RESEARCH AND TECHNOLOGICAL INNOVATION. GRANT SUBMISSIONS UNDERGO RIGOROUS PEER REVIEW BY THE FOUNDATION'S SCIENTIFIC ADVISORY COMMITTEE OR RECOMMENDED SUBJECT MATTER EXPERTS AND ARE HELD TO THE STRICTEST STANDARDS OF SCIENTIFIC EXCELLENCE. 33898449 1 1 0 0 0 0 0 0 0 0 1 1 0 0 1 1 1 0 0 0 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 53 0 1 9 1 0 0 0 0 0 0 0 0 0 0 0 0 X 6 5 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 NY X IAN LESSER 6468665950 1350 AVENUE OF THE AMERICAS SUITE NEW YORK NY 10019 ALEX KNASTER DIRECTOR 1.00 X 0 0 0 ROSS LEVINE DIRECTOR 1.00 X 10000 0 0 NICOLA MENDEHLSON DIRECTOR 1.00 X 0 0 0 PAUL POSPISIL DIRECTOR 1.00 X 0 0 0 OTMAR D WIESTLER DIRECTOR 1.00 X 0 0 0 RAYMOND DUBOIS EXECUTIVE CHAIRMAN OF THE BOARD 24.00 X X 560000 0 0 RYAN SCHOENFELD CHIEF EXECUTIVE OFFICER 40.00 X 506697 0 54667 IAN LESSER DIRECTOR FINANCE & ADMINISTRATION 40.00 X 172733 0 42983 ANNA TURETSKY TO 724 PRINCIPAL, VENTURE INVESTMENTS 40.00 X 327122 0 21607 REBECCA BISH-CORNELISSEN HEAD DISCOVERY/PRE-CLINICAL RESEARCH 40.00 X 310646 0 51139 AMY FEHIR HEAD OF DEVELOPMENT 40.00 X 215995 0 30535 REBECCA LIU DIRECTOR, GRANTS ADMINISTRATION 40.00 X 197094 0 34568 MICHAEL CARLETON SENIOR SCIENTIFIC DIRECTOR 40.00 X 175776 0 47706 ROBERT MAGIN ASSOCIATE SCIENTIFIC DIRECTOR 40.00 X 169179 0 20443 2645242 0 303648 10 0 1 0 ARNOLD & PORTER KAYE SCHOLER LLP 601 MASSACHUSETTS AVE NW WASHINGTON DC 200013743 LEGAL SERVICES 205035 YOUR PART TIME CONTROLLER 1500 WALNUT STREET PHILADELPHIA PA 19102 ACCOUNTING 185495 THE ONE NINE THREE GROUP LLC 231 PANTIGO RD SUITE 2 EAST HAMPTON NY 11937 PUBLIC RELATIONS 170000 SWISSOTEL CHICAGO 321 E WACKER DRIVE CHICAGO IL 60601 TRAVEL/EVENT COSTS 124113 4 44393676 44393676 708202 708202 3455522 3748870 4982 -293348 -4982 -298330 -298330 FOREIGN EXCHANGE LOSS 900099 -30647 -30647 -30647 44772901 0 0 379225 19856597 19856597 10676470 10676470 1695809 1184904 231050 279855 621680 431432 85031 105217 35266 27508 2578 5180 171790 112392 31805 27593 137623 94177 19584 23862 246685 129836 107477 9372 251079 251079 28856 28856 956290 369112 192771 394407 13553 194 11371 1988 26111 64 26047 407932 267604 60782 79546 243551 182583 26160 34808 249177 248929 248 104950 68847 15638 20465 28430 28430 HONORARIA 183350 183350 BOOKS AND SUBSCRIPTIONS 73323 38560 5116 29647 RECRUITING FEES 20094 500 19594 PAYROLL PROCESSING FEES 17574 10117 5241 2216 20560 15273 3898 1389 36066750 33898449 1152756 1015545 3483399 4163153 18877966 1199468 62373066 67188474 3029739 2074290 136382 181430 249931 196500 95170 53431 12298546 14916600 17110500 1580066 1190422 104492388 105459714 625207 508742 18102751 11578247 1287461 932955 20015419 13019944 X 80853903 83738330 3623066 8701440 84476969 92439770 104492388 105459714 X 8706151 -1884750 1141400 X 0 1 X 1 0 X 40000110 32001882 55001677 39897754 44393676 211295099 40000110 32001882 55001677 39897754 44393676 211295099 20202782 191092317 182602 141133 363707 1035039 708202 2430683 -4552 -19890 9740 -30647 -45349 213680433 0.89430 0.69490 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: FOREIGN EXCHANGE LOSSES GAINS - 2021 AMOUNT: $ -4,552. 2022 AMOUNT: $ -19,890. 2023 AMOUNT: $ 9,740. 2024 AMOUNT: $ -30,647. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 74759 49967 24792 175172 146533 28639 53431 PRIVATE PREFERRED STOCK 17110500 F 17110500 LEASE LIABILITY 932955 932955 X 42886495 -1884750 27200 -1857550 44744045 28856 28856 44772901 34923694 27200 27200 34896494 28856 1141400 1170256 36066750 PART X, LINE 2: THE FOUNDATION FOLLOWS THE PROVISIONS OF THE FINANCIAL ACCOUNTING STANDARDS BOARD'S (THE "FASB") ACCOUNTING STANDARDS CODIFICATION ("ASC") TOPIC 740, INCOME TAXES, AS IT RELATES TO ACCOUNTING AND REPORTING FOR UNCERTAINTY IN INCOME TAXES. BECAUSE OF THE FOUNDATION'S GENERAL TAX-EXEMPT STATUS, MANAGEMENT BELIEVES, ASC TOPIC 740 HAS NOT HAD, AND IS NOT ANTICIPATED TO HAVE, A MATERIAL IMPACT ON THE FOUNDATION'S FINANCIAL STATEMENTS. PART XII, LINE 4B - OTHER ADJUSTMENTS: PRIOR YEAR AWARDS AMENDED/RETURNED GRANTS AWARDED AND NETTED AGAINST CURRENT YEAR GRANT EXPENSE IN AUDITED FINANCIAL STATEMENTS 1,141,400. 1 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTMAKING 8223556 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTMAKING 1300000 EAST ASIA AND THE PACIFIC 0 0 GRANTMAKING 714278 NORTH AMERICA 0 0 GRANTMAKING 438636 0 0 0 0 0 0 10676470 0 10676470 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 4330333 WIRE 0 MIDDLE EAST AND NORTH AFRICA RESEARCH 1300000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 1000000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 668948 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 429939 WIRE 0 EAST ASIA AND THE PACIFIC RESEARCH 381921 WIRE 0 EAST ASIA AND THE PACIFIC RESEARCH 255118 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 250000 WIRE 0 NORTH AMERICA RESEARCH 249964 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 249646 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 249234 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 249187 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 243100 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 200000 WIRE 0 NORTH AMERICA RESEARCH 188672 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 180000 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 121245 WIRE 0 EAST ASIA AND THE PACIFIC RESEARCH 77239 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 51115 WIRE 0 17 2 0 0 0 0 0 0 PART I, LINE 2: THE FOUNDATION AWARDS RESERACH GRANTS BASED UPON THE GUIDANCE AND INPUT OF THE FOUNDATION'S SCIENTIFIC ADVISORY COMMITTEE AND OTHER HIGHLY REGARDED SCIENTISTS SPECIALIZING IN CANCER RESEARCH. THE FOUNDATION CLOSELY MONITORS THE PROGRESS OF EACH GRANT AWARDED. THERE IS FREQUENT COMMUNICATION BETWEEN GRANTEES AND FOUNDATION STAFF REGARDING THE PROGRESS OF EACH GRANT. IN THE CASE OF MULTI-YEAR GRANTS, PROGRESS IS VERIFIED BEFORE ADDITIONAL GRANTS ARE AWARDED. PART I, LINE 3: AMOUNTS REPORTED USING THE ACCRUAL METHOD OF ACCOUNTING. 1 ASPEN CANCER CONFERENCE INC 419 MEADOW COURT BASALT CO 81621 521746776 501(C)(3) 25000 0 RESEARCH CALIFORNIA INSTITUTE OF TECHNOLOGY 1200 E CALIFORNIA BLVD MC 103-6 PASADENA CA 91125 951643307 501(C)(3) 250000 0 RESEARCH CHILDREN'S NATIONAL MEDICAL CENTER 111 MICHIGAN AVENUE NW WASHINGTON DC DC 20010 521640403 501(C)(3) 90000 0 RESEARCH COLD SPRING HARBOR LABORATORY 1 BUNGTOWN RD PO BOX 100 COLD SPRING HARBOR NY 11724 112013303 501(C)(3) 750000 0 RESEARCH DAMON RUNYON WALTER WINCHELL FOUNDATION ONE EXCHANGE PLAZA NEW YORK NY 10006 131933825 501(C)(3) 413436 0 RESEARCH DANA FARBER CANCER INSTITUTE INC 450 BROOKLINE AVENUE BOSTON MA 022150000 042263040 501(C)(3) 355000 0 RESEARCH JOHNS HOPKINS UNIVERSITY 3910 KESWICKROAD N-4327B BALTIMORE MD 21211 520595110 501(C)(3) 1384340 0 RESEARCH MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT STREET BOSTON MA 02114 042697983 501(C)(3) 698007 0 RESEARCH MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 100656007 131924236 501(C)(3) 1568007 0 RESEARCH NEW YORK UNIVERSITY SCHOOL OF MEDICINE 550 FIRST AVENUE NEW YORK NY 10016 135562308 501(C)(3) 570775 0 RESEARCH NORTHWESTERN UNIVERSITY 633 CLARK ST EVANSTON IL 60208 362167817 501(C)(3) 198825 0 RESEARCH PRESIDENT AND FELLOWS OF HARVARD COLLEGE 1033 MASSACHUSETTS AVE CAMBRIDGE MA 02138 042103580 501(C)(3) 711352 0 RESEARCH REGENTS OF THE UNIVERSITY OF CALIFORNIA BERKELEY 2195 HEARST AVENUE BERKELEY CA 947201101 946002123 501(C)(3) 90000 0 RESEARCH REGENTS OF THE UNIVERSITY OF CALIFORNIA IRVINE 324 ALDRICH HALL IRVINE CA 926977600 952226406 501(C)(3) 698007 0 RESEARCH REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO 1855 FOLSOM ST SUITE 425 SAN FRANCISCO CA 941430812 946036493 501(C)(3) 2299837 0 RESEARCH REGENTS OF THE UNIVERSITY OF MICHIGAN 5082 WOLVERINE TOWER 3003 SOUTH STATE STREET ANN ARBOR MI 481091287 386006309 501(C)(3) 698007 0 RESEARCH SAMUEL WAXMAN CANCER RESEARCH FOUNDATION 420 LEXINGTON AVENUE NEW YORK NY 101700899 133020943 501(C)(3) 11250 0 RESEARCH THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 485 BROADWAY REDWOOD CITY CA 94063 941156365 501(C)(3) 948007 0 RESEARCH THE JACKSON LABORATORY 600 MAIN STREET BAR HARBOR ME 04609 010211513 501(C)(3) 332133 0 RESEARCH THE SALK INSTITUTE FOR BIOLOGICAL STUDIES 10010 N TORREY PINES RD LA JOLLA CA 920371002 952160097 501(C)(3) 1000000 0 RESEARCH THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 615 WEST 131 STREET 3RD FLOOR NEW YORK NY 10027 135598093 501(C)(3) 2750000 0 RESEARCH THE UNIVERSITY OF TEXAS AT AUSTIN 110 INNER CAMPUS DR STOP K5300 AUSTIN TX 78712 746000203 501(C)(3) 125217 0 RESEARCH THE UNIVERSITY OF TEXAS SOUTHWESTERN 5323 HARRY HINES BLVD MC9029 DALLAS TX 753909029 756002868 501(C)(3) 500000 0 RESEARCH UNIVERSITY OF ALABAMA AT BIRMINGHAM 801 5TH AVE SOUTH ROOM 251 BIRMINGHAM AL 35233 636005396 501(C)(3) 1000000 0 RESEARCH UNIVERSITY OF MIAMI PO BOX 405803 ATLANTA GA 303845803 590624458 501(C)(3) 250000 0 RESEARCH UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 116 ATWOOD STREET SUITE 201 PITTSBURGH PA 15260 250965591 501(C)(3) 1000000 0 RESEARCH UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BLVD HOUSTON TX 770307009 746001118 501(C)(3) 175000 0 RESEARCH WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY 1300 YORK AVENUE NEW YORK NY 10065 131623978 501(C)(3) 125000 0 RESEARCH YALE UNIVERSITY 25 SCHIENCE PARK 3RD FL NEW HAVEN CT 065113571 060646973 501(C)(3) 467841 0 RESEARCH 29 PART I, LINE 2: THE FOUNDATION REQUIRES GRANT RECIPIENTS TO COMPLY WITH STATED TERMS AND CONDITIONS GOVERNING EACH RESEARCH PROGRAM AWARDED, INCLUDING THE SUBMISSION OF PROGRESS REPORTS. DISBURSEMENT OF FUNDS IS CONTINGENT UPON ACCEPTANCE OF THESE TERMS AND TIMELY SUBMISSION OF REPORTS. X X X 1 0 0 0 0 0 0 1 0 RYAN SCHOENFELD CHIEF EXECUTIVE OFFICER 364333 0 142364 0 0 0 12075 0 42592 0 561364 0 0 0 RAYMOND DUBOIS EXECUTIVE CHAIRMAN OF THE BOARD 560000 0 0 0 0 0 0 0 0 0 560000 0 0 0 REBECCA BISH-CORNELISSEN HEAD DISCOVERY/PRE-CLINICAL RESEARCH 254655 0 55991 0 0 0 8178 0 42961 0 361785 0 0 0 ANNA TURETSKY TO 724 PRINCIPAL, VENTURE INVESTMENTS 163744 0 47586 0 115792 0 4941 0 16666 0 348729 0 0 0 AMY FEHIR HEAD OF DEVELOPMENT 192662 0 23333 0 0 0 3833 0 26702 0 246530 0 0 0 REBECCA LIU DIRECTOR, GRANTS ADMINISTRATION 167602 0 29492 0 0 0 7064 0 27504 0 231662 0 0 0 MICHAEL CARLETON SENIOR SCIENTIFIC DIRECTOR 150776 0 25000 0 0 0 5250 0 42456 0 223482 0 0 0 IAN LESSER DIRECTOR FINANCE & ADMINISTRATION 165733 0 7000 0 0 0 0 0 42983 0 215716 0 0 0 ROBERT MAGIN ASSOCIATE SCIENTIFIC DIRECTOR 142669 0 26510 0 0 0 5916 0 14527 0 189622 0 0 0 PART I, LINE 4A SEVERANCE PAYMENT MADE DURING 2024 IS DISCLOSED IN PART II, COLUMN B(III) FOR ONE INDIVIDUAL. PART I, LINE 7 STAFF BONUSES ARE AWARDED ON A DISCRETIONARY BASIS UPON THE RECOMMENDATION OF THE CHIEF EXCECUTIVE OFFICER AND APPROVAL BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11B A COPY OF THE FOUNDATION'S 990 IS PROVIDED TO THE BOARD OF DIRECTORS FOR REVIEW AND COMMENT PRIOR TO ITS ELECTRONIC FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C ALL MEMBERS OF THE BOARD OF DIRECTORS AND KEY MEMBERS OF MANAGEMENT ARE REQUIRED TO REVIEW THE CONFLICTS-OF-INTEREST POLICY AND SIGN IT ON AN ANNUAL BASIS. FORM 990, PART VI, SECTION B, LINE 15 THE EXECUTIVE CHAIRMAN OF THE BOARD SERVES AS A STRATEGIC ADVISOR TO THE FOUNDATION, PROVIDING GOVERNANCE LEADERSHIP, WHICH INCLUDES OVERSEEING BOARD MEETINGS, GUIDING STRATEGIC DECISIONS, AND ENSURING COMPLIANCE WITH THE FOUNDATION'S BY-LAWS. ADDITIONALLY, THE EXECUTIVE CHAIRMAN OFFERS FUNDRAISING SUPPORT AND PERFORMS OTHER SERVICES TYPICALLY ASSOCIATED WITH SUCH A POSITION, SUCH AS MENTORING SENIOR LEADERSHIP AND REPRESENTING THE FOUNDATION IN EXTERNAL ENGAGEMENTS. THE FOUNDATION'S BOARD CONDUCTS AN ANNUAL REVIEW OF THE EXECUTIVE CHAIRMAN'S PROFESSIONAL FEE TO ENSURE IT IS COMPETITIVE. THIS REVIEW INCLUDES A COMPARISON OF FEES PAID BY SIMILARLY SIZED PEER ORGANIZATIONS IN THE SAME GEOGRAPHIC LOCATION FOR SIMILAR SERVICES, HELPING THE FOUNDATION ATTRACT AND RETAIN HIGH-CALIBER LEADERSHIP. THE CHIEF EXECUTIVE OFFICER'S COMPENSATION IS REVIEWED ON AN ANNUAL BASIS BY THE BOARD OF DIRECTORS USING COMPARABLE MARKET DATA. COMPENSATION OF KEY EMPLOYEES IS DETERMINED BY THE CHIEF EXECUTIVE OFFICER, AND APPROVED BY THE BOARD OF DIRECTORS ON AN ANNUAL BASIS, AS A PART OF THE FOUNDATION'S BUDGET PROCESS. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION'S FORM 990 IS AVAILABLE UPON REQUEST. GOVERNING DOCUMENTS ARE ONLY DISTRIBUTED INTERNALLY TO THE BOARD OF DIRECTORS AND MANAGEMENT. FORM 990, PART XI, LINE 9: PRIOR YEAR AWARDS AMENDED/RETURNED GRANTS 1,141,400.